| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.27 | 6e-07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |